Basit öğe kaydını göster

dc.contributor.authorAkbaba, Eren
dc.contributor.authorAkbaba, Gulhan
dc.date.accessioned2020-11-20T15:06:26Z
dc.date.available2020-11-20T15:06:26Z
dc.date.issued2015
dc.identifier.issn1302-0072
dc.identifier.issn2147-2688
dc.identifier.urihttps://doi.org/10.4274/haseki.2003
dc.identifier.urihttps://hdl.handle.net/20.500.12809/3131
dc.descriptionWOS: 000216753300002en_US
dc.description.abstractPrimary ovarian failure (POF) is a common cause of infertility in women. It is characterized by amenorrhea, hypoestrogenism and elevated gonadotropin levels in women younger than 40 years of age. Primary causes of POF are the X chromosome abnormalities (monosomy, trisomy, translocation, deletion) or genetic defects that can occur as a result of autosomal gene mutations. Autoimmune ovarian damage may be seen alone or may be associated with some autoimmune diseases or syndromes; but the specificity and sensitivity of ovarian antibodies is still under debate. Bilateral oophorectomy, chemotherapy, radiotherapy and infections cause the secondary POF. Symptoms of POF include irritability, nervousness, loss of libido, depression, dry skin, vaginal dryness and frequent infections. POF is diagnosed with FSH levels higher than 40 IU/L and estradiol levels below 50 pmol/L in women younger than 40 years of age. For the patients who desire pregnancy, consecutive estrogen-progesterone replacement therapy is the first step treatment, and oocyte donation may be advised thereafter. Suitable estrogen-progesterone treatment improves quality of life, and protects patients from complications such as osteoporosis, cardiovascular disease and stroke. Pregnancy has been obtained with assisted conception held by donated oocytes in women with POF. Cryopreservation of oocytes, embryos and ovarian tissue is used to preserve ovarian reserve in women undergoing cancer treatments.en_US
dc.item-language.isoengen_US
dc.publisherGalenos Yayinciliken_US
dc.item-rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectPrimary Ovarian Failureen_US
dc.subjectOvarian Follicle Dysfunctionen_US
dc.subjectInfertilityen_US
dc.subjectHormone Replacement Therapyen_US
dc.titlePrimary Ovarian Failureen_US
dc.item-typereviewen_US
dc.contributor.departmenten_US
dc.contributor.departmentTemp[Akbaba, Eren] Mugla Sitki Kocman Univ, Fac Med, Dept Endocrinol & Metab Dis, Mugla, Turkey -- [Akbaba, Gulhan] Mugla Sitki Kocman Univ, Fac Med, Dept Gynecol & Obstretr, Obstretr Dept Endocrinol & Metab, Mugla, Turkeyen_US
dc.identifier.doi10.4274/haseki.2003
dc.identifier.volume53en_US
dc.identifier.issue1en_US
dc.identifier.startpage10en_US
dc.identifier.endpage15en_US
dc.relation.journalHaseki Tip Bulteni-Medical Bulletin of Hasekien_US
dc.relation.publicationcategoryDiğeren_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster